EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
批准号:
6615546
负责人:
ELLIOTT D KIEFF
金额:
$70.51万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-20 至 2005-06-30
关键词:
AP1 protein B lymphocyte CD40 molecule Caenorhabditis elegans Epstein Barr virus I kappa B beta apoptosis cAMP response element binding protein cell membrane clinical research cytokine receptors cytoskeleton epidermal growth factor genetic promoter element genetic transcription genetically modified animals growth factor receptors human subject laboratory mouse membrane proteins neoplasm /cancer genetics nuclear factor kappa beta recombinant virus tumor necrosis factor alpha viral carcinogenesis virus genetics virus protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (as per abstract) The objective is to develop sufficient knowledge
of the molecular mechanisms by which LMP1 alters cell growth and of the effects
of inhibiting those mechanisms so as to design screens for inhibitors that
might be effective in treating EBV associated malignancies. The specific goals
are to: (1) Use recombinant EBV based genetics to clarify the role of specific
LMP1 amino acids (aa) in primary B lymphocyte growth transformation. The focus
will be on aa between transformation effector site 1 (TES1) and TES2, TES1,
TES2 and aa within the transmembrane domains. (2) Determine whether LMP1
signals through interactions with other receptors. LMP1 association with
membrane rafts, with cytoskeletal elements, and with other membrane proteins,
particularly TNFRs, will be investigated using genetic, biochemical, and
physiological approaches. (3) Determine the mechanisms by which N-terminally
truncated IkB causes apoptosis of EBV transformed cells so as to better
validate inhibition of NFkB as a therapeutic target. (4) Investigate the
cytoplasmic effects of LMP1, including the molecular mechanisms by which LMP1
and CD40 recruit TRAFs, modify TRAFs, activate NIK and ASK, effect NIK and ASK1
interaction with downstream kinases, and continuously signal or return to a
basal state. (5) Determine the effects of LMP1 on B lymphocytes and epithelial
gene expression from the changes in RNAs following expression of LMP1, LMP1
TES1, LMP1 TES2, or LMP1 with null mutations in TES1 and TES2. The importance
of NFkB, AP1, CREB, or other factor activations will be evaluated by analyses
of relevant promoters, e.g., TRAF1, EGFR, and CD40. The effects of LMP1TES1 and
LMP1TES2 on cell gene transcription and on transformation will be compared with
the effects of LMP1 and LMP1/CD40 in transgenic mice. (6) Evaluate the role of
TRAF3 in LMP1, CD40, and LTbetaR signaling through observing differences in
RNAs with LMP1 expression or CD40 or LTbetaR activation in TRAF3 knockout
versus normal mouse cells or mice. The role of PKN in TRAF3 effects on the cell
cytoskeleton, membranes, or transcription will also be assessed. (7)
Investigate the role of C. elegans TRAF3 homologue in C. elegans neural
function so as to enable screens for interacting genes that might identify
novel TRAF functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Epstein-Barr Virus super-enhancers
-
批准号:9082368
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2016
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
-
批准号:8634754
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2013
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
-
批准号:8820800
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2013
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
-
批准号:8506671
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2013
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
-
批准号:7746412
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2008
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
-
批准号:8400899
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2008
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
-
批准号:7988583
-
项目类别:
-
资助金额:$35.84万
-
财政年份:2008
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
-
批准号:7583461
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2008
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
-
批准号:8196893
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2008
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Screening of Epstein Barr Virus Replication (RMI)
-
批准号:6879777
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2004
-
负责人:ELLIOTT D KIEFF
-
依托单位:
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
-
批准号:6776477
-
项目类别:
-
资助金额:$72.63万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP1-Mediated Oncogenecity
-
批准号:8585029
-
项目类别:
-
资助金额:$68.04万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
-
批准号:7460802
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP1-Mediated Oncogenecity
-
批准号:8403187
-
项目类别:
-
资助金额:$65.93万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
-
批准号:7168173
-
项目类别:
-
资助金额:$73.48万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
-
批准号:6514372
-
项目类别:
-
资助金额:$68.46万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP-1 Mediated Oncongenicity
-
批准号:7877759
-
项目类别:
-
资助金额:$71.48万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
-
批准号:7666704
-
项目类别:
-
资助金额:$72.55万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
Epstein-Barr Virus LMP1-Mediated Oncogenecity
-
批准号:8263567
-
项目类别:
-
资助金额:$70.14万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
-
批准号:6040654
-
项目类别:
-
资助金额:$64.53万
-
财政年份:2000
-
负责人:ELLIOTT D KIEFF
-
依托单位:
海外基金